-
Something wrong with this record ?
Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison
P. Leptourgos, M. Fortier-Davy, R. Carhart-Harris, PR. Corlett, D. Dupuis, AL. Halberstadt, M. Kometer, E. Kozakova, F. LarØi, TN. Noorani, KH. Preller, F. Waters, Y. Zaytseva, R. Jardri
Language English Country United States
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
UL1 TR001863
NCATS NIH HHS - United States
NV17-32957A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
Free Medical Journals
from 2006 to 1 year ago
PubMed Central
from 2006 to 1 year ago
Europe PubMed Central
from 2006 to 1 year ago
Medline Complete (EBSCOhost)
from 1996-01-01 to 1 year ago
- MeSH
- Hallucinations chemically induced diagnostic imaging etiology physiopathology MeSH
- Hallucinogens adverse effects MeSH
- Humans MeSH
- Nerve Net diagnostic imaging drug effects physiopathology MeSH
- Schizophrenia complications diagnostic imaging physiopathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Comparative Study MeSH
The recent renaissance of psychedelic science has reignited interest in the similarity of drug-induced experiences to those more commonly observed in psychiatric contexts such as the schizophrenia-spectrum. This report from a multidisciplinary working group of the International Consortium on Hallucinations Research (ICHR) addresses this issue, putting special emphasis on hallucinatory experiences. We review evidence collected at different scales of understanding, from pharmacology to brain-imaging, phenomenology and anthropology, highlighting similarities and differences between hallucinations under psychedelics and in the schizophrenia-spectrum disorders. Finally, we attempt to integrate these findings using computational approaches and conclude with recommendations for future research.
Department of Anthropology University of Durham Durham UK
Department of Psychiatry Connecticut Mental Health Center Yale University New Haven CT
Department of Psychiatry University of California San Diego La Jolla CA
Department of Psychology Faculty of Arts Charles University Prague Czechia
Imperial College London London UK
Norwegian Center of Excellence for Mental Disorders Research University of Oslo Oslo Norway
Psychology and Neuroscience of Cognition Research Unit University of Liège Liège Belgium
Research Service VA San Diego Healthcare System San Diego CA
School of Psychological Sciences The University of Western Australia Perth Western Australia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004799
- 003
- CZ-PrNML
- 005
- 20220127144947.0
- 007
- ta
- 008
- 220113s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/schbul/sbaa117 $2 doi
- 035 __
- $a (PubMed)32944778
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Leptourgos, Pantelis $u Department of Psychiatry, Connecticut Mental Health Center, Yale University, New Haven, CT
- 245 10
- $a Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison / $c P. Leptourgos, M. Fortier-Davy, R. Carhart-Harris, PR. Corlett, D. Dupuis, AL. Halberstadt, M. Kometer, E. Kozakova, F. LarØi, TN. Noorani, KH. Preller, F. Waters, Y. Zaytseva, R. Jardri
- 520 9_
- $a The recent renaissance of psychedelic science has reignited interest in the similarity of drug-induced experiences to those more commonly observed in psychiatric contexts such as the schizophrenia-spectrum. This report from a multidisciplinary working group of the International Consortium on Hallucinations Research (ICHR) addresses this issue, putting special emphasis on hallucinatory experiences. We review evidence collected at different scales of understanding, from pharmacology to brain-imaging, phenomenology and anthropology, highlighting similarities and differences between hallucinations under psychedelics and in the schizophrenia-spectrum disorders. Finally, we attempt to integrate these findings using computational approaches and conclude with recommendations for future research.
- 650 _2
- $a halucinace $x chemicky indukované $x diagnostické zobrazování $x etiologie $x patofyziologie $7 D006212
- 650 _2
- $a halucinogeny $x škodlivé účinky $7 D006213
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nervová síť $x diagnostické zobrazování $x účinky léků $x patofyziologie $7 D009415
- 650 _2
- $a schizofrenie $x komplikace $x diagnostické zobrazování $x patofyziologie $7 D012559
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Fortier-Davy, Martin $u Institut Jean Nicod, École des Hautes Études en Sciences Sociales, École Normale Supérieure, PSL Research University, Paris France
- 700 1_
- $a Carhart-Harris, Robin $u Imperial College London, London, UK
- 700 1_
- $a Corlett, Philip R $u Department of Psychiatry, Connecticut Mental Health Center, Yale University, New Haven, CT
- 700 1_
- $a Dupuis, David $u Department of Anthropology, University of Durham, Durham, UK
- 700 1_
- $a Halberstadt, Adam L $u Department of Psychiatry, University of California San Diego, La Jolla, CA $u Research Service, VA San Diego Healthcare System, San Diego, CA
- 700 1_
- $a Kometer, Michael $u Pharmaco-Neuroimaging and Cognitive-Emotional Processing, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Kozakova, Eva $u Department of Applied Neurosciences and Brain Imaging, National Institute of Mental Health, Klecany, Czechia $u Department of Psychology, Faculty of Arts, Charles University, Prague, Czechia
- 700 1_
- $a LarØi, Frank $u Department of Biological and Medical Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway $u Psychology and Neuroscience of Cognition Research Unit, University of Liège, Liège, Belgium $u Norwegian Center of Excellence for Mental Disorders Research, University of Oslo, Oslo, Norway
- 700 1_
- $a Noorani, Tehseen N $u Department of Anthropology, University of Durham, Durham, UK
- 700 1_
- $a Preller, Katrin H $u Pharmaco-Neuroimaging and Cognitive-Emotional Processing, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Waters, Flavie $u School of Psychological Sciences, The University of Western Australia, Perth, Western Australia
- 700 1_
- $a Zaytseva, Yuliya $u Department of Applied Neurosciences and Brain Imaging, National Institute of Mental Health, Klecany, Czechia $u Department of Psychiatry and Medical Psychology, 3rd Faculty of Medicine, Charles University in Prague, Prague, Czechia
- 700 1_
- $a Jardri, Renaud $u Univ. Lille, INSERM U1172, CHU Lille, Lille Neuroscience & Cognition Centre (LiNC), Plasticity & SubjectivitY team, Lille, France $u Laboratoire de Neurosciences Cognitives et Computationnelles, ENS, INSERM U960, PSL Research University, Paris, France
- 773 0_
- $w MED00004355 $t Schizophrenia bulletin $x 1745-1701 $g Roč. 46, č. 6 (2020), s. 1396-1408
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32944778 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127144944 $b ABA008
- 999 __
- $a ok $b bmc $g 1752097 $s 1155948
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 46 $c 6 $d 1396-1408 $e 20201201 $i 1745-1701 $m Schizophrenia bulletin $n Schizophr Bull $x MED00004355
- GRA __
- $a UL1 TR001863 $p NCATS NIH HHS $2 United States
- GRA __
- $a NV17-32957A $p MZ0
- LZP __
- $a Pubmed-20220113
